These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27600610)

  • 1. Effect of combined treatment of radiation and tissue-specific recombinant oncolytic adenovirus on bladder cancer cells.
    Zhang H; Wang F; Mao C; Zhang Z; Fu S; Lu J; Zhai Z; Li R; Li S; Rodriguez R; Wang Z
    Int J Radiat Biol; 2017 Feb; 93(2):174-183. PubMed ID: 27600610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.
    Wang L; Zhang Y; Zhao J; Xiao E; Lu J; Fu S; Wang Z
    Tumour Biol; 2014 Nov; 35(11):10879-90. PubMed ID: 25085582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.
    Wang F; Wang Z; Tian H; Qi M; Zhai Z; Li S; Li R; Zhang H; Wang W; Fu S; Lu J; Rodriguez R; Guo Y; Zhou L
    Curr Gene Ther; 2012 Apr; 12(2):67-76. PubMed ID: 22384806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.
    Zhai Z; Wang Z; Fu S; Lu J; Wang F; Li R; Zhang H; Li S; Hou Z; Wang H; Rodriguez R
    Gene Ther; 2012 Nov; 19(11):1065-74. PubMed ID: 22218302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
    Cao W; Tian J; Li C; Gao Y; Liu X; Lu J; Wang Y; Wang Z; Svatek RS; Rodriguez R
    Virol J; 2017 Aug; 14(1):149. PubMed ID: 28789701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro.
    Shi J; Fu S; Wang L; Tao Y; Rodriguez R; Wang Z
    Anticancer Drugs; 2017 Jan; 28(1):88-96. PubMed ID: 27622605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.
    He XD; Wang ZP; Wei HY; Zhou Q; Wang DG; Tian JQ; Fu SJ; Rodriguez R
    Urol Int; 2009; 82(2):209-13. PubMed ID: 19322012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.
    Rajecki M; af Hällström T; Hakkarainen T; Nokisalmi P; Hautaniemi S; Nieminen AI; Tenhunen M; Rantanen V; Desmond RA; Chen DT; Guse K; Stenman UH; Gargini R; Kapanen M; Klefström J; Kanerva A; Pesonen S; Ahtiainen L; Hemminki A
    Int J Cancer; 2009 Nov; 125(10):2441-9. PubMed ID: 19672857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratogenic Toxicity Evaluation of Bladder Cancer-Specific Oncolytic Adenovirus on Mice.
    Lu K; Wang F; Ma B; Cao W; Guo Q; Wang H; Rodriguez R; Wang Z
    Curr Gene Ther; 2021; 21(2):160-166. PubMed ID: 33334289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.
    Lei W; Liu HB; Wang SB; Zhou XM; Zheng SD; Guo KN; Ma BY; Xia YL; Tan WS; Liu XY; Wang YG
    Acta Pharmacol Sin; 2013 Apr; 34(4):531-40. PubMed ID: 23503473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy.
    Li S; Wang F; Zhai Z; Fu S; Lu J; Zhang H; Guo H; Hu X; Li R; Wang Z; Rodriguez R
    Oncol Lett; 2017 Aug; 14(2):2081-2088. PubMed ID: 28781650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer.
    Ramesh N; Ge Y; Ennist DL; Zhu M; Mina M; Ganesh S; Reddy PS; Yu DC
    Clin Cancer Res; 2006 Jan; 12(1):305-13. PubMed ID: 16397056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
    Wu CL; Shieh GS; Chang CC; Yo YT; Su CH; Chang MY; Huang YH; Wu P; Shiau AL
    Clin Cancer Res; 2008 Feb; 14(4):1228-38. PubMed ID: 18281558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Suppression Effect on Tumor Growth of Colorectal Cancer by Combining Radiotherapy With a TRAIL-Armed Oncolytic Adenovirus.
    Gao H; Zhang X; Ding Y; Qiu R; Hong Y; Chen W
    Technol Cancer Res Treat; 2019; 18():1533033819853290. PubMed ID: 31138083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery.
    Kuroda S; Fujiwara T; Shirakawa Y; Yamasaki Y; Yano S; Uno F; Tazawa H; Hashimoto Y; Watanabe Y; Noma K; Urata Y; Kagawa S; Fujiwara T
    Cancer Res; 2010 Nov; 70(22):9339-48. PubMed ID: 21045143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.